These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2887409)

  • 1. Inhibition of 2-deoxy-glucose-induced glucagon secretion by muscarinic and alpha-adrenoceptor blockade in the mouse.
    Karlsson S; Ahrén B
    Diabetes Res Clin Pract; 1987; 3(4):239-42. PubMed ID: 2887409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of 2-deoxy-glucose-induced insulin secretion in the mouse.
    Karlsson S; Bood M; Ahrén B
    J Auton Pharmacol; 1987 Jun; 7(2):135-44. PubMed ID: 3308892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism.
    Karlsson S; Ahrén B
    Metabolism; 1990 Jul; 39(7):724-32. PubMed ID: 1973257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism for the inhibitory action of 2-deoxy-glucose on thyroid hormone secretion in the mouse.
    Ahrén B; Hedner P
    Neuroendocrinology; 1989 May; 49(5):471-5. PubMed ID: 2725841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic effect of 2-deoxy-D-glucose on plasma glucagon levels in conscious rats.
    Haito K; Takeda A; Kagawa S; Shimizu S; Matsuoka A
    Horm Metab Res; 1984 Dec; 16 Suppl 1():110-3. PubMed ID: 6398250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neither adrenergic nor cholinergic antagonists in the central nervous system affect 2-deoxy-D-glucose(2-DG)-induced hyperglycemia.
    Iguchi A; Gotoh M; Matsunaga H; Yatomi A; Uemura K; Miura H; Kunoh Y; Tamagawa T; Sakamoto N
    Brain Res; 1990 Mar; 510(2):321-5. PubMed ID: 1970507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice.
    Havel PJ; Akpan JO; Curry DL; Stern JS; Gingerich RL; Ahren B
    Am J Physiol; 1993 Jul; 265(1 Pt 2):R246-54. PubMed ID: 8102036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-adrenoceptor blockade by phentolamine inhibits beta-adrenergically and cholinergically induced glucagon secretion in the mouse.
    Ahrén B; Lundquist I
    Horm Metab Res; 1987 Dec; 19(12):600-3. PubMed ID: 2894339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of autonomic blockade by methylatropine and optical isomers and propranolol on plasma insulin levels in the basal state and after stimulation.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1981 May; 112(1):57-63. PubMed ID: 7025578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin releasing peptide (GRP): effects on basal and stimulated insulin and glucagon secretion in the mouse.
    Pettersson M; Ahrén B
    Peptides; 1987; 8(1):55-60. PubMed ID: 3554168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system-mediated glucagon secretion is enhanced by alpha 2-adrenoreceptor activation.
    Iguchi A; Gotoh M; Matsunaga H; Yatomi A; Uemura K; Miura H; Satake T; Tamagawa T; Sakamoto N
    Endocrinology; 1989 Sep; 125(3):1581-6. PubMed ID: 2569393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent involvement of autonomic nervous system in hyperglycemia due to 2-deoxy-D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E928-33. PubMed ID: 2904768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin and glucagon responses to intravenous infusion of propionate and their autonomic control in sheep.
    Sano H; Hattori N; Todome Y; Tsuruoka J; Takahashi H; Terashima Y
    J Anim Sci; 1993 Dec; 71(12):3414-22. PubMed ID: 7904990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat.
    Marubashi S; Tominaga M; Katagiri T; Yamatani K; Yawata Y; Hara M; Sasaki H
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):6-10. PubMed ID: 2857512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic nervous system control of glucagon secretion during neuroglucopenia.
    Asplin CM; Werner PL; Halter JB; Hollander PM; Palmer JP
    Endocrinology; 1983 May; 112(5):1585-9. PubMed ID: 6339209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the autonomic antagonists on canine urethral responses to autonomic nerve stimulation.
    Nishizawa O; Moriya I; Fukuda T; Matsuzaki A; Tsuchida S
    Urol Int; 1985; 40(6):314-9. PubMed ID: 2868555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal regulation of insulin, glucagon, and somatostatin secretion in vitro in the rat.
    Nishi S; Seino Y; Ishida H; Seno M; Taminato T; Sakurai H; Imura H
    J Clin Invest; 1987 Apr; 79(4):1191-6. PubMed ID: 2881948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia induced by electrical stimulation of lateral part of dorsal parabrachial nucleus.
    Fujiwara T; Nagai K; Takagi S; Nakagawa H
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E468-75. PubMed ID: 2895585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.